Skip to content

SCPHARMACEUTICALS INC.

CIK 0001604950

← back to feed
Revenue (TTM)
$45.87M
+167.3% YoY Q2 Aug 2025
Net Income (TTM)
−$89.96M
−55.4% YoY Q2 Aug 2025
EPS Diluted (TTM)
−$1.90
−34.5% YoY Q2 Aug 2025
Gross Margin
69.3%
Q2 Aug 2025
Operating Margin
-140.9%
Q2 Aug 2025
Net Margin
-196.1%
Q2 Aug 2025
Free Cash Flow (TTM)
−$58.72M
Q2 Aug 2025
Cash
$40.81M
Q2 Aug 2025
Total Debt
$61.08M
Q2 Aug 2025
Shares Outstanding
53.3M sh
Q2 Aug 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings